RecruitingNot ApplicableNCT06722508

Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients


Sponsor

University of California, Davis

Enrollment

20 participants

Start Date

May 9, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study examines the acceptability, feasibility, and safety in developing a prehabilitation program for head and neck cancer patients. The purpose of this research is to access the safety and acceptability of using a prehabilitation program before head and neck cancer surgery.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • New head and neck cancer diagnosis Age \> 18

Exclusion Criteria12

  • Prior treatment for head and neck cancer (surgery and/or radiation)
  • Acute or unstable cardiac conditions (unstable angina or symptomatic severe aortic stenosis)
  • American Society of Anesthesiologists physical status of 4 and 5
  • Disabling orthopedic or neuromuscular disease
  • Cardiac failure (New York Heart Association functional classes III and IV)
  • Severe chronic obstructive pulmonary disease
  • End-stage liver or kidney disease
  • Inability to swallow and/or feeding tube dependence
  • Any other comorbid medical, physical, and/or mental condition that contraindicates exercise or oral nutrition
  • Adults unable to consent
  • Age 17.99 or younger
  • Prisoners, pregnant women, or other vulnerable population

Interventions

BEHAVIORALexercise and nutritional prehabilitation

The study involves a behavioral intervention (exercise and nutritional prehabilitation) designed to assess outcomes related to feasibility, acceptability, and safety in head and neck cancer patients. Outcomes are being measured following the intervention over a defined period (from diagnosis through 1-month post-surgery).


Locations(2)

UC Davis Health

Sacramento, California, United States

UC Davis Medical Center

Sacramento, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06722508


Related Trials